Medical diagnostic company Shimadzu Medical Systems USA reported on Monday the receipt of the US FDA 510(k) clearance for the patient side conventional radiographic/fluoroscopic (RF) table system, FLUOROspeed X1.
With immediate market launch, the company's new radiographic/fluoroscopic (RF) FLUOROspeed X1 table system offers a high image quality and a multitude of features that improve work flow and operator efficiencies which contributes to lower cost of care.
A part of the FLUOROspeed series, the company's new FLUOROspeed X1 with its 665lb static patient weight and 500lb all motion weight, easily performs both bariatric and routine daily fluoroscopic and radiographic exams. It is practically priced and comes equipped with a 17"x17" dynamic digital X-ray detector (FPD) in the table bucky allowing be used for both fluoroscopy as well as radiographic exams.
The 31.5-inch aperture opening between table top and deck also provides access for imaging patients in wheelchairs as well as fits in smaller rooms. Adding the second X-ray tube on an overhead rail, the FLUOROspeed X1's functionality and versatility increases exponentially, concluded the company.
FDA approval streamlines access to Bristol Myers Squibb CAR T cell therapies
Emmaus Life Sciences' Endari label enhancements receive US FDA approval
Accord Healthcare introduces Dehydrated Alcohol Injection for cardiovascular indications
CARsgen Therapeutics' satri-cel NDA accepted by Chinese regulator
Sanofi receives FDA orphan drug designation for riliprubart in transplant rejection
Hoth Therapeutics reports positive interim results for HT-001 topical therapy
Breckenridge Pharmaceutical's generic for Ablysinol granted final FDA approval
Hemab Therapeutics presents bleeding disorder clinical and preclinical data at ISTH 2025 Congress